Selective induction of inducible nitric oxide synthase in pancreatic islet of rat after an intravenous glucose or intralipid challenge

Nutrition

Volumn 22, Issue 6, 2006, Pages 652-660

  Ekelund, Mats ^a   Qader, Saleem S ^a   Jimenez Feltstrom, Javier ^b   Salehi, Albert ^b  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY   (Sweden)

Author keywords

Glucose challenge; Inducible nitric oxide synthase; Insulin secretion; Pancreatic islets

Indexed keywords

FATTY ACID; GLUCAGON; GLUCOSE; INDUCIBLE NITRIC OXIDE SYNTHASE; INSULIN; INTRALIPID;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; CHEMICAL ANALYSIS; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INDUCTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOCYTOCHEMISTRY; MALE; NONHUMAN; NUTRIENT; PANCREAS ISLET; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROVOCATION TEST; RAT; WESTERN BLOTTING;

ADMINISTRATION, ORAL; ANIMALS; BLOOD GLUCOSE; BLOTTING, WESTERN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FAT EMULSIONS, INTRAVENOUS; GLUCAGON; GLUCOSE; IMMUNOHISTOCHEMISTRY; INFUSIONS, INTRAVENOUS; INSULIN; ISLETS OF LANGERHANS; MALE; NITRIC OXIDE SYNTHASE TYPE II; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY;

ANIMALIA;

EID: 33646398356     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nut.2006.01.006     Document Type: Article

References (51)

1. Salehi A., Chen D., Håkanson R., Nordin G., and Lundquist I. Gastrectomy induces impaired insulin and glucagon secretion. evidence for a gastro-insular axis in mice. J Physiol 514 (1999) 579-591
2. Sudo T., Ishiyama K., Takemoto M., Kawamura M., Umemura H., and Shiraha S. Pancreatic endocrine function after total gastrectomy and truncal vagotomy. Am J Surg 144 (1982) 539-544
3. Vigili d., Kreutzenberg S., Lisato G., Riccio A., Giunta F., Bonato R., and Petolillo M. Metabolic control during total parenteral nutrition. use of an artificial endocrine pancreas. Metabolism 37 (1988) 510-513
4. Robertson R.P., Harmon J., Tran P.O., and Poitout V. Beta-cell glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes. Diabetes 53 suppl 1 (2004) 119-124
5. Salehi A., Ekelund M., Henningsson R., and Lundquist I. Total parenteral nutrition modulates hormone release by stimulating expression and activity of inducible nitricoxide synthase in rat pancreatic islets. Endocrine 16 (2001) 97-104
6. Salehi A., Ekelund M., and Lundquist I. Total parenteral nutrition-stimulated activity ofinducible nitric oxide synthase in rat pancreatic islets is suppressed by glucagon-like peptide-1. Horm Metab Res 35 (2003) 48-54
7. Krauss S., Zhang C.Y., Scorrano L., Dalgaard L.T., St-Pierre J., Grev S.T., and Lowell B.B. Superoxide-mediated activation of uncoupling protein 2 causes pancreatic beta cell dysfunction. J Clin Invest 112 (2003) 1831-1842
8. Corbett J.A., and McDaniel M.L. Does nitric oxide mediate autoimmune destruction of beta-cells? Possible therapeutic interventions in IDDM. Diabetes 41 (1992) 897-903
9. Salehi A., Carlberg M., Henningson R., and Lundquist I. Islet constitutive nitric oxidesynthase. biochemical determination and regulatory function. Am J Physiol 270 (1996) 1634-1641
10. Delaney C.A., and Eizirik D.L. Intracellular targets for nitric oxide toxicity to pancreatic beta-cells. Braz J Med Biol Res 29 (1996) 569-579
11. Delaney C.A., Tyrberg B., Bouwens L., Vaghef H., Hellman B., and Eizirik D.L. Sensitivity of human pancreatic islets to peroxynitrite-induced cell dysfunction and death. FEBS Lett 394 (1996) 300-306
12. Alderton W.K., Cooper C.E., and Knowles R.G. Nitric oxide synthases. structure, function and inhibition. Biochem J 357 (2001) 593-615
13. Forstermann U., and Kleinert H. Nitric oxide synthase. expression and expressional control of the three isoforms. Naunyn Schmiedebergs Arch Pharmacol 352 (1995) 351-364
14. Henningsson R., Salehi A., and Lundquist I. Role of nitric oxide synthase isoforms in glucose-stimulated insulin release. Am J Physiol Cell Physiol 283 (2002) C296-C304
15. Shimabukuro M., Ohneda M., Lee Y., and Unger R.H. Role of nitric oxide in obesity-induced beta cell disease. J Clin Invest 100 (1997) 290-295
16. Knapke C.M., Owens J.P., and Mirtallo J.M. Management of glucose abnormalities in patients receiving total parenteral nutrition. Clin Pharm 8 (1989) 136-144
17. Quirk J. Malnutrition in critically ill patients in intensive care units. Br J Nurs 9 (2000) 537-541
18. Salehi zA., Fan B.G., Ekelund M., Nordin G., and Lundquist I. TPN-evoked dysfunction of islet lysosomal activity mediates impairment of glucose-stimulated insulin release. Am J Physiol Endocrinol Metab 281 (2001) E171-E179
19. Ljungqvist O., and Soreide E. Preoperative fasting. Br J Surg 90 (2003) 400-406
20. Ljungqvist O., Thorell A., Gutniak M., Haggmark T., and Efendic S. Glucose infusion instead of preoperative fasting reduces postoperative insulin resistance. J Am Coll Surg 178 (1994) 329-336
21. Fan B.G., Salehi A., Sternby B., Axelson J., Lundquist I., Andren-Sandberg A., and Ekelund M. Total parenteral nutrition influences both endocrine and exocrine function of rat pancreas. Pancreas 15 (1997) 147-153
22. Gotoh M., Maki T., Kiyoizumi T., Satomi S., and Monaco A.P. An improved method for isolation of mouse pancreatic islets. Transplantation 40 (1985) 437-438
23. Qader S.S., Ekelund M., Andersson R., Obermuller S., and Salehi A. Acute pancreatitis, expression of inducible nitric oxide synthase and defective insulin secretion. Cell Tissue Res 313 (2003) 271-279
24. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72 (1976) 248-254
25. Unger R.H. Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Genetic and clinical implications. Diabetes 44 (1995) 863-870
26. Eizirik D.L., Flodstrom M., Karlsen A.E., and Welsh N. The harmony of the spheres. inducible nitric oxide synthase and related genes in pancreatic beta cells. Diabetologia 394 (1996) 875-890
27. Eizirik D.L., Delaney C.A., Green M.H., Cunningham J.M., Thorpe J.R., Pipeleers D.G., et al. Nitric oxide donors decrease the function and survival of human pancreatic islets. Mol Cell Endocrinol 118 (1996) 71-83
28. de-Mello M.A., Flodstrom M., and Eizirik D.L. Ebselen and cytokine-induced nitric oxide synthase expression in insulin-producing cells. Biochem Pharmacol 52 (1996) 1703-1709
29. Ammon H.P., and Mark M. Thiols and pancreatic beta-cell function. a review. Cell Biochem Funct 3 (1985) 157-171
30. Welsh N., and Sandler S. Interleukin-1 beta induces nitric oxide production and inhibits the activity of aconitase without decreasing glucose oxidation rates in isolated mouse pancreatic islets. Biochem Biophys Res Commun 182 (1992) 333-340
31. Tsuura Y., Ishida H., Hayashi S., Sakamoto K., Horie M., and Seino Y. Nitric oxide opens ATP-sensitive K+channels through suppression of phosphofructokinase activity and inhibits glucose-induced insulin release in pancreatic beta cells. J Gen Physiol 104 (1994) 1079-1098
32. Tsuura Y., Ishida H., Shinomura T., Nishimura M., and Seino Y. Endogenous nitric oxide inhibits glucose-induced insulin secretion by suppression of phosphofructokinase activity in pancreatic islets. Biochem Biophys Res Commun 252 (1998) 34-38
33. Ceriello A., Quagliaro L., D'Amico M., Di Filippo C., Marfella R., Nappo F., et al. Acute hyperglycemia induces nitrotyrosine formation and apoptosis in perfused heart from rat. Diabetes 51 (2002) 1076-1082
34. Kajimoto Y., and Kaneto H. Role of oxidative stress in pancreatic beta-cell dysfunction. Ann N Y Acad Sci 1011 (2004) 168-176
35. Harmon J.S., Gleason C.E., Tanaka Y., Poitout V., and Robertson R.P. Antecedent hyperglycemia, not hyperlipidemia, is associated with increased islet triacylglycerol content and decreased insulin gene mRNA level in Zucker diabetic fatty rats. Diabetes 50 (2001) 2481-2486
36. N'Guyen J.M., Magnan C., Laury M.C., Thibault C., Leveteau J., Gilbert M., et al. involvement of autonomic nervous system in the in vivo memory to glucose of pancreatic βcell in rats. Clin Invest 94 (1994) 1456-1462
37. Busch A.K., Cordery D., Denyer G.S., and Biden T.J. Expression profiling of palmitate- and oleate-regulated genes provides novel insights into the effects of chronic lipid exposure on pancreatic beta-cell function. Diabetes 51 (2002) 977-987
38. Kim W.H., Lee J.W., Suh Y.H., Hong S.H., Choi J.S., Lim J.H., et al. Exposure to chronic high glucose induces {beta}-cell apoptosis through decreased interaction of glucokinase with mitochondria. downregulation of glucokinase in pancreatic {beta}-cells. Diabetes 54 (2005) 2602-2611
39. Wang X., Li H., De Leo D., Guo W., Koshkin V., Fantus I.G., et al. Gene and protein kinase expression profiling of reactive oxygen species-associated lipotoxicity in the pancreatic beta-cell line M1N6. Diabetes 53 (2004) 129-140
40. Hansotia T., and Drucker D.J. GIP and GLP-1 as incretin hormones. lessons from single and double incretin receptor knockout mice. Regul Pept 128 (2005) 125-134
41. Holst J.J., and Orskov C. The incretin approach for diabetes treatment. modulation of islet hormone release by GLP-1 agonism. Diabetes 53 suppl 3 (2004) 197-204
42. Herbach N., Goeke B., Schneider M., Hermanns W., Wolf E., and Wank R. Overexpression of a dominant negative GIP receptor in transgenic mice results in disturbed postnatal pancreatic islet and beta-cell development. Regul Pept 125 (2005) 103-117
43. Preitner F., Ibberson M., Franklin I., Binnert C., Pende M., Gjinovci A., et al. Gluco-incretins control insulin secretion at multiple levels as revealed in mice lacking GLP-1 and GIP receptors. J Clin Invest 113 (2004) 635-645
44. Jiang G., and Zhang B.B. Glucagon and regulation of glucose metabolism. Am J Physiol Endocrinol Metab 284 (2003) E671-E678
45. Shah P., Vella A., Basu A., Schwenk W.F., and Rizza R.A. Lack of suppression of glucagon contributes to postprandial hyperglycemia in subjects with type 2 diabetes mellitus. J Clin Endocrinol Metab 85 (2000) 4053-4059
46. Henningsson R., Alm P., Lindstrom E., and Lundquist I. Chronic blockade of NO synthase paradoxically increases islet NO production and modulates islet hormone release. Am J Physiol Endocrinol Metab 279 (2000) E95-E107
47. Salehi A., Parandeh F., and Lundquist I. Signal transduction in islet hormone release. interaction of nitric oxide with basal and nutrient-induced hormone responses. Cell Signal 10 (1998) 645-651
48. Lupi R., Dotta F., Marselli L., Del Guerra S., Masini M., et al. Prolonged exposure to free fatty acids has cytostatic and pro-apoptotic effects on human pancreatic islets. evidence that beta-cell death is caspase mediated, partially dependent on ceramide pathway, and Bcl-2 regulated. Diabetes 51 (2002) 1437-1442
49. Koshkin V., Wang X., Scherer P.E., Chan C.B., and Wheeler M.B. Mitochondrial functional state in clonal pancreatic beta-cells exposed to free fatty acids. J Biol Chem 278 (2003) 19709-19715
50. Heitmeier M.R., Arnush M., Scarim A.L., and Corbett J.A. Pancreatic beta-cell damage mediated by beta-cell production of interleukin-1. A novel mechanism for virus-induced diabetes. J Biol Chem 276 (2001) 11151-11158
51. Gerich J.E., Langlois M., Schneider V., Karam J.H., and Noacco C. Effects of alternations of plasma free fatty acid levels on pancreatic glucagon secretion in man. J Clin Invest 53 (1974) 1284-1289